Tulane University Receives Funding for T-prop Treatment
Researchers in New Orleans secured a $4 million federal contract to develop an immune-boosting infection treatment.
Live Poll
Do you support prioritizing the development of rapid, temporary immune treatments over traditional long-term vaccines?